LearnGlossaryMarketStocksSuperinvestorsSign in

GRDX

GridAI Technologies Corp.

Healthcare · $11M market cap

Verdict

We can't put a fair value on GRDX right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-61.7% a year✗
Sales growth—?
Free cash flow growth—?
Return on invested capital-22.8%✗

Follow GRDX

Track it on your watchlist and see the full analysis. Free.

Create a free account

About GridAI Technologies Corp.

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works